clinical trial · NCT05591755
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
Seasonal Allergic ConjunctivitisBrimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic SolutionKetotifen fumarate ophthalmic solution 0.035%Brimonidine tartrate ophthalmic solution 0.025%Experimental: Vehicle ophthalmic solution
brief summary
To evaluate the efficacy of Combo compared to its individual components and compared to vehicle in a population of subjects with seasonal allergic conjunctivitis.
started
Nov 18, 2022
primary completion
Aug 9, 2023
completion
Aug 9, 2023
last updated
Jul 1, 2025
official title
Evaluation of the Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to Its Components and Vehicle in an Allergen BioCube® in Subjects With Seasonal Allergic Conjunctivitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol